Evaluation of mutant frequencies of chemically induced tumors and normal tissues in λ/cII transgenic mice

Environmental and Molecular Mutagenesis

Volumn 45, Issue 1, 2005, Pages 17-35

  Mirsalis, Jon C ^a   Shimon, Julie A ^a   Johnson, Alphonso ^a   Fairchild, David ^a   Kanazawa, Nathan ^a   Nguyen, Tung ^a   De Boer, Johan ^b   Glickman, Barry ^b   Winegar, Richard A ^c  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF VICTORIA   (Canada)

^c MIDWEST RESEARCH INSTITUTE   (United States)

Author keywords

Carcinogenesis; Genomic instability; Mutagenesis; Transgenic animals

Indexed keywords

DIETHYLNITROSAMINE; DRINKING WATER; OXAZEPAM; PHENOBARBITAL; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CELL MUTANT; CLONAL VARIATION; CONTROLLED STUDY; DIET; DNA DAMAGE; EVALUATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOME; GENOTOXICITY; HISTOPATHOLOGY; LIVER INJURY; LIVER TUMOR; LUNG ADENOMA; LUNG PARENCHYMA; MALE; METASTASIS; MOLECULAR CLONING; MOUSE; MUTATION; NONHUMAN; PHENOTYPE; TRANSGENIC MOUSE; TUMOR VOLUME;

ANIMALS; CARCINOGENS; CLONE CELLS; DIETHYLNITROSAMINE; FEMALE; GENE FREQUENCY; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, TRANSGENIC; MUTATION; OXAZEPAM; PHENOBARBITAL;

ANIMALIA; MUS MUSCULUS;

EID: 13444311536     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20084     Document Type: Article

References (41)

1. Abelson PH. 1993. Health risk assessment. Regul Toxicol Pharmacol 17:219-223.
2. Andley UP, Song Z, Wawrousek EF, Brady JP, Bassnett S, Fleming TP. 2001. Lens epithelial cells derived from alphaB-crystallin knock-out mice demonstrate hyperproliferation and genomic instability. FASEB J 15:221-229.
3. Burkle A. 2001. Poly(APD-ribosyl)ation, a DNA damage-driven protein modification and regulator of genomic instability. Cancer Lett. 163:1-5.
4. Canitrot Y, Frechet M, Servant L, Cazaux C, Hoffmann JS. 1999. Overexpression of DNA polymerase beta: a genomic instability enhancer process. FASEB J 13:1107-1111.
5. Cheah PY, Eu KW, Seow FC. 2000. Update of genetics in colorectal carcinomas: genomic instability and somatic evolution. Ann Acad Med Singapore 29:331-336.
6. Coleman WB, Tsongalis GJ. 1999. The role of genomic instability in human carcinogenesis. Anticancer Res 19:4645-4664.
7. Duensing S, Munger K. 2001. Centrosome abnormalities, genomic instability and carcinogenic progression. Biochim Biophys Acta 1471:M81-M88.
8. Eiben R. 2001. Frequency and time trends of spontaneous tumors found in B6C3F1 mice oncogenicity studies over 10 years. Exp Toxicol Pathol 53:399-408.
9. Falzetti D, Crescenzi B, Matteuci C, Falini B, Martelli MF, Van Den Berghe H, Mecucci C. 1999. Genomic instability and recurrent breakpoints are main cytogenetic findings in Hodgkin's disease. Haematologica 84:298-305.
10. Fest T, Mougey V, Daistein V, Hagerty M, Milette D, Silva S, Mai S. 2002. c-MYC overexpression in Ba/F3 cells simultaneously elicits genomic instability and apoptosis. Oncogene 21:2981-2990.
11. Friedlander PL. 2001. Genomic instability in head and neck cancer patients. Head Neck 23:683-691.
12. Griffith JK, Bryant JE, Fordyce CA, Gilliland FD, Joste NE, Moyzis RK. 1999. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma. Breast Cancer Res Treat 54:59-64.
13. Heddle JA, Dean S, Nohmi T, Boerrigter M, Casciano D, Douglas GR, Glickman BW, Gorelick NJ, Mirsalis JC, Martus HJ, Skopek TR, Thybaud V, Tindall KR, Yajima N. 2000. In vivo transgenic mutation assays. Environ Mol Mutagen 35:253-259.
14. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez Salguero PM, Morgan WF, Deng CX, Fornace AJ Jr. 1999. Genomic instability in Gadd45a-deficient mice. Nat Genet 23:176-184.
15. Jakubczak JL, Merlino G, French JE, Muller WJ, Paul B, Adhya S, Garges S. 1996. Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage λ transgene target. Proc Natl Acad Sci 93:9073-9078.
16. Kramer A, Neben K, Ho AD. 2002. Centrosome replication, genomic instability and cancer. Leukemia 16:767-775.
17. Loeb LA. 1991. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079.
18. Lung JC, Chu JS, Yu JC, Yue CT, Lo YL, Shen CY, Wu CW. 2002. Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Genes Chromosomes Cancer 34:276-284.
19. McClain RM. 1990. Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital. Prog Clin Biol Res 331:345-65.
20. Mirsalis JC, Monforte JA, Winegar RA. 1994. Transgenic animal models for measuring mutations in vivo. Crit Rev Toxicol 24:255-280.
21. Monroe JJ, Manjanatha MG, Skopek TR. 2001. Extent of CpG methylation is not proportional to the in vivo spontaneous mutation frequency at transgenic loci in Big Blue rodents. Mutat Res 476:1-11.
22. Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, Wakabayashi K. 1997a. Evidence for increased somatic cell mutations in patients with hepatocellular carcinoma. Carcinogenesis 18:445-449.
23. Okada N, Honda A, Kawabata M, Yajima N. 1997b. Sodium phenobarbital-enhanced mutation frequency in the liver DNA of lacZ transgenic mice treated with diethylnitrosamine. Mutagenesis 12:179-184.
24. Ong TM, Song B, Qian HW, Wu ZL, Whong WZ. 1998. Detection of genomic instability in lung cancer tissues by random amplified polymorphic DNA analysis. Carcinogenesis 19:233-235.
25. Reynolds TY, Rockwell S, Glazer PM. 1996. Genetic instability induced by the tumor microenvironment. Cancer Res 56:5754-5757.
26. Rizwana R, Hahn PJ. 1999. CpG methylation reduces genomic instability. J Cell Sci 112:4513-4519.
27. Robles AI, Harris CC. 2001. p53-mediated apoptosis and genomic instability diseases. Acta Oncol 40:696-701.
28. Rockwell S, Yuan J, Peretz S, Glazer PM. 2001. Genomic instability in cancer. Novartis Found Symp 240:133-142.
29. Saavedra HI, Knauf JA, Shirokawa JM, Wang J, Ouyang B, Elisei R, Stambrook PJ, Fagin JA. 2000. The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway. Oncogene 19:3948-3954.
30. Savelyeva L, Claas A, Matzner I, Schlag P, Hofmann W, Scherneck S, Weber B, Schwab M. 2001. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers. Cancer Res 61:5179-5185.
31. Schmutte C, Fishel R. 1999. Genomic instability: first step to Carcinogenesis. Anticancer Res 19:4665-4696.
32. Shane BS, Smith Dunn DL, deBoer JG, Glickman BW, Cunningham ML. 2000. Subchronic administration of phenobarbital alters the mutation spectrum of lacI in the livers of Big Blue transgenic mice. Mutat Res 448:69-80.
33. Shin DM, Charuruks N, Lippman SM, Lee JJ, Ro JY, Hong WK, Hittelman WN. 2001. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis. Cancer Epidemiol Biomarkers Prev 10:603-609.
34. Singh VK, Ganesh L, Cunningham ML, Shane BS. 2001. Comparison of the mutant frequencies and mutation spectra of three non-genotoxic carcinogens, oxazepam, phenobarbital, and Wyeth 14,643, at the lambda cII locus in Big Blue transgenic mice. Biochem Pharmacol 62:685-692.
35. Stoler DL, Datta RV, Charles MA, Block AW, Brenner BM, Sieczka EM, Hicks WL Jr, Loree TR, Anderson GR. 2002. Genomic instability measurement in the diagnosis of thyroid neoplasms. Head Neck 24:290-295.
36. Stuart GR, Oda Y, de Boer J, Glickman B. 2000. Mutation frequency and specificity with age in liver, bladder and brain of lacI transgenic mice. Genetics 154:1291-1300.
37. Su ZZ, Gopalkrishnan RV, Narayan G, Dent P, Fisher PB. 2002. Progression elevated gene-3, PEG-3, induces genomic instability in rodent and human tumor cells. J Cell Physiol 192:34-44.
38. van Brabant AJ, Stan R, Ellis NA. 2000. DNA helicases, genomic instability, and human genetic disease. Annu Rev Genomics Hum Genet 1:409-59.
39. Vessey CJ, Norbury CJ, Hickson ID. 1999. Genetic disorders associated with cancer predisposition and genomic instability. Prog Nucl Acid Res Mol Biol 63:189-221.
40. Voelkel-Johnson C, Voeks DJ, Greenberg NM, Barrios R, Maggouta F, Kurtz DT, Schwartz DA, Keller GM, Papenbrock T, Clawson GA, Norris JS. 2000. Genomic instability-based transgenic models of prostate cancer. Carcinogenesis 21:1623-1627.
41. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. 1988. Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532.